These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7949496)

  • 1. Assessment of 24-hour gastric pH measurements in trauma patients receiving intravenous famotidine by intermittent bolus versus continuous infusion administration.
    Jones LA; Gonzalez ER; Reines HD; Venitz J
    Ann Pharmacother; 1994; 28(7-8):841-4. PubMed ID: 7949496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effect of intermittent administration and continuous infusion of famotidine on gastric pH in critically ill patients: results of a prospective, randomized, crossover study.
    Baghaie AA; Mojtahedzadeh M; Levine RL; Fromm RE; Guntupalli KK; Opekun AR
    Crit Care Med; 1995 Apr; 23(4):687-91. PubMed ID: 7712759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of intermittent and continuous intravenous infusion of famotidine on gastric acidity in patients with peptic ulcers.
    Watanabe Y; Tsumura H; Sasaki H; Morimoto T
    Clin Ther; 1990; 12(6):534-46. PubMed ID: 2289221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of an intravenous bolus of famotidine and Mylanta II for the control of gastric pH in critically ill patients.
    Wilson P; Clark GW; Anselmino M; Welch NT; Singh S; Perdikis G; Hinder RA
    Am J Surg; 1993 Dec; 166(6):621-4; discussion 624-5. PubMed ID: 8273840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized comparison of gastric pH control with intermittent and continuous intravenous infusion of famotidine in ICU patients.
    Heiselman DE; Hulisz DT; Fricker R; Bredle DL; Black LD
    Am J Gastroenterol; 1995 Feb; 90(2):277-9. PubMed ID: 7847300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric acid suppression is greater during intravenous ranitidine infusion versus bolus injections of famotidine.
    Hogan DL; McQuaid KR; Koss MA; Crombie DL; Hunter S; Metz C; Euler AR; Isenberg JI
    Aliment Pharmacol Ther; 1993 Oct; 7(5):537-41. PubMed ID: 8280822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bolus or intravenous infusion of ranitidine: effects on gastric pH and acid secretion. A comparison of relative efficacy and cost.
    Ballesteros MA; Hogan DL; Koss MA; Isenberg JI
    Ann Intern Med; 1990 Mar; 112(5):334-9. PubMed ID: 2306061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bolus infusion of famotidine: effects on gastric pH by repeated 12-hour doses of 20 mg in postoperative patients.
    Savarino V; Mela GS; Zentilin P; Larghero G; Cutela P; Mele MR; Vassallo A; Mansi C; Dallorto E; Celle G
    J Clin Pharmacol; 1994 Feb; 34(2):148-52. PubMed ID: 8163715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamics of bolus famotidine versus infused cimetidine, ranitidine, and famotidine.
    Amsden GW; Goss TF; Harrison NJ; D'Andrea DT; Schentag JJ
    J Clin Pharmacol; 1994 Dec; 34(12):1191-8. PubMed ID: 7738215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A controlled comparison of continuous ranitidine and intermittent famotidine infusions on gastric pH.
    Bachmann K; Sullivan TJ; Jauregui L
    J Clin Pharmacol; 1993 Dec; 33(12):1219-24. PubMed ID: 7907348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of famotidine and ranitidine in critically ill children.
    Madani S; Kauffman R; Simpson P; Lehr VT; Lai ML; Sarniak A; Tolia V
    J Clin Pharmacol; 2014 Feb; 54(2):201-5. PubMed ID: 24258773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance of gastric pH above 6 with intravenous famotidine in patients with a bleeding duodenal ulcer.
    Delchier JC; el Amine I; Roudot-Thoraval F; Elouaer-Blanc L; Lamarque D; Stanescu L
    Aliment Pharmacol Ther; 1995 Apr; 9(2):191-6. PubMed ID: 7605861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of two dosing regimens of intravenous ranitidine on gastric pH in critically ill children.
    Osteyee JL; Banner W
    Am J Crit Care; 1994 Jul; 3(4):267-72. PubMed ID: 7920954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intravenous famotidine on gastric acid secretion in patients undergoing cardiac surgery.
    Wagner BK; Amory DW; Majcher CM; DiFazio LT; Scott GE; Spotnitz AJ
    Ann Pharmacother; 1995 Apr; 29(4):349-53. PubMed ID: 7633009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous infusion versus intermittent bolus dosing of vecuronium in patients receiving therapeutic hypothermia after sudden cardiac arrest.
    Jurado LV; Gulbis BE
    Pharmacotherapy; 2011 Dec; 31(12):1250-6. PubMed ID: 22122185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective, randomized comparison of lansoprazole suspension, and intermittent intravenous famotidine on gastric pH and acid production in critically ill neurosurgical patients.
    Brophy GM; Brackbill ML; Bidwell KL; Brophy DF
    Neurocrit Care; 2010 Oct; 13(2):176-81. PubMed ID: 20596795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of over-the-counter famotidine and calcium carbonate antacid on postprandial gastric acid. A randomized controlled trial.
    Feldman M
    JAMA; 1996 May; 275(18):1428-31. PubMed ID: 8618369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of gastric acid secretion by intravenous administration of famotidine in children.
    Treem WR; Davis PM; Hyams JS
    J Pediatr; 1991 May; 118(5):812-6. PubMed ID: 2019939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four-day continuous gastric pH monitoring following anti-acid secretory drug administration: cross-over test to assess the early effects.
    Suzuki T; Yamaguchi T; Odaka T; Kobayashi M; Seza A; Kouzu T; Yokosuka O
    Aliment Pharmacol Ther; 2008 Jan; 27(1):66-71. PubMed ID: 17922801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of two ranitidine intravenous infusion regimens in critically ill patients.
    Marchant J; Summers K; McIsaac RL; Wood JR
    Aliment Pharmacol Ther; 1988 Feb; 2(1):55-63. PubMed ID: 2979234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.